Xian-Xin Zhang

Xian-Xin Zhang currently serves as Executive Director at Frontage Laboratories, Inc. since October 2015, where responsibilities include managing CMC Analytical Service teams, ensuring GMP compliance, and overseeing analytical method development and validation for new and generic drug development. Prior to this role, Xian-Xin Zhang was Director of Analytical and Stability Center at WuXi AppTec from August 2014 to October 2015, focusing on operational management and analytical R&D. Other positions held include Sr. Manager at Clinical Metabolomics, Principal Scientist at Teva Pharmaceuticals, and Sr. Scientist at Arena Pharmaceuticals, with experience dating back to Sr. and Principal Scientist at Watson from May 2001 to December 2006. Xian-Xin Zhang holds a Doctor of Philosophy (Ph.D.) in Analytical/Physical Chemistry from Brigham Young University.